Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001344676-25-000030·GAGNON SECURITIES LLC
Schedule 13G ownership disclosure
Treace Medical Concepts Inc
Common stock, $0.001 par value · CUSIP: 89455T109
Event date: 2025-05-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Gagnon Securities LLC
Shares: 2,709,970.00 · Class: 4.3%
- Gagnon Advisors, LLC
Shares: 830,270.00 · Class: 1.3%
- Neil Gagnon
Shares: 3,979,454.00 · Class: 6.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001344676-25-000030
- Form type
- SCHEDULE 13G
- Filer
- GAGNON SECURITIES LLC
- CIK
- CIK 1125725
- Filed
- May 15, 2025
- Reporting period
- May 09, 2025
- Description
- Schedule 13G beneficial ownership